Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is ...

SINGAPORE – At just 10 years old, Ridhwan Fadli was hospitalised with a severe respiratory illness that triggered a heart ...

Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction with preserved left ventricular ejection fraction (LVEF).

The mineralocorticoid receptor antagonist did not reduce primary outcomes in the CLEAR SYNERGY trial, but there was a suggestion that it did prevent new or worsening heart failure.

In this prospective cohort of patients with acute myocardial infarction (AMI), plasma progranulin levels increased acutely ...

Acute myocardial infarction, commonly referred to as a heart attack, happens when the heart muscle's blood supply is suddenly interrupted, resulting in tissue damage. This is usually the result of a ...

Objectives Elevations of cardiac troponin T (cTnT) levels are common after strenuous exercise. We assessed whether the ...

For ventricular tachycardia after myocardial infarction, outcomes are better with upfront catheter ablation than drug therapy ...

Women who drink 4 glasses of regular milk every day have a higher risk of heart disease, a new study has found. Fermented ...

The research, published in the European Heart Journal, revealed that cold weather may increase the susceptibility to ...

Proposed in the early 1980s as a solution for managing complications of portal hypertension, the percutaneous creation of ...

Part 2 of this 7,000-patient trial suffered from discontinuations and low event rates: still, early MRAs did not impact CV ...